Skip to main content

FDA approves GSK RSV vaccine

GSK's Arexvy, the first RSV vaccine approved for use in the U.S., gets the green light for older adults.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.